bounce time, page-11

The only difference i can see in the quarterly conference to the last will be that we will be told what a wonderfull bit of timing the cap raise was The quarterly after that at the very least will show a little bit of income from Unifill sales after Sanofi get their share . Hopoefully it will also include some income from Sanofi but I am still of the opinion that it will be at some time between september and end of year and therefore income from sanofi is unlikely in even that quarter. To complete my wish list an outside possibility of an upfront payment for exclusivity from a third pharma re another device before septembers quarterly would be nice but could be as late as april